<DOC>
	<DOCNO>NCT01780675</DOCNO>
	<brief_summary>Using Intensity Modulated radiotherapy possible treat entire brain standard dosages whole-brain radiation , keep radiation dose hippocampus low . However , clear relationship radiation dose damage hippocampal stem cell establish yet . This study initiate investigate early delay neurotoxicity PCI ass randomise design benefit risk spar hippocampus Small Cell Lung Cancer patient receive PCI .</brief_summary>
	<brief_title>Hippocampus Avoidance PCI v PCI</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>− Small Cell Lung Cancer patient ( stage IIII stage IV without clinical radiological evidence brain metastasis ) candidate PCI , i.e . without progressive disease chemoradiotherapy stage IIII remission chemotherapy stage IV Sufficient proficiency Dutch Prior radiotherapy brain Clinical evidence brain metastasis primary brain tumors− Evidence progressive extracranial metastatic disease Previous malignancy &lt; 2 year ago except adequately treat basal cell carcinoma skin carcinoma situ cervix Any systemic anticancer treatment PCI within 3 week start PCI Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Prophylactic Cranial Irradiation</keyword>
	<keyword>Hippocampal Avoidance Prophylactic Cranial Irradiation</keyword>
</DOC>